Tiny particles added to focused radiation for cancer that has spread to the brain
Original title: Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a middle stage test in people, and it has no results yet.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests if tiny particles can make brain radiation work better.
Who this trial is for. This trial is for people with cancer that has spread to the brain and is hard to control with focused radiation alone. Some people get focused radiation alone, and others get it along with tiny particles called AGuIX.
Where it stands. The team wants to learn if the particles help the radiation work better. This trial has not reported results yet. The answer is not in.
What this means, and what it doesn't
What it could mean: If you have cancer that has spread to the brain, you could ask your care team about this trial. They can tell you if it might fit you. Only the trial team decides who can join.
What it doesn't mean: This trial is a test, not a proven treatment. Being in it does not mean it will help you. It is not a cure. No one knows yet if the particles help at all.
Source: ClinicalTrials.gov, September 9, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.